HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wyatt, D. A. Articles by Mentzer, R. M. Search for Related Content PubMed PubMed Citation Articles by Wyatt, D. A. Articles by Mentzer, R. M., Jr

The Journal of Thoracic and Cardiovascular Surgery, Vol 97, 771-778, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Purine-enriched asanguineous cardioplegia retards adenosine triphosphate degradation during ischemia and improves postischemic ventricular function

DA Wyatt, SW Ely, RD Lasley, R Walsh, R Mainwaring, RM Berne and RM Mentzer Jr
Department of Surgery, University of Virginia, Charlottesville.

Myocardial dysfunction after induced ischemic arrest is an important problem in cardiac surgery. Adenosine-5'-triphosphate content in myocardial tissue remains depressed for days after ischemia, perhaps because of reperfusion washout of diffusable purine substrates. Left ventricular function is also depressed after ischemia, but its relationship to absolute tissue adenosine triphosphate content is unclear. We tested the hypothesis that arresting hearts with a cardioplegic solution containing adenosine, hypoxanthine, and ribose would result in improved tissue adenosine triphosphate content and left ventricular function after 1 hour of normothermic global ischemia in dogs supported by cardiopulmonary bypass. Animals with ischemic arrest initiated with a crystalloid cardioplegic solution containing adenosine 100 mumol/L, hypoxanthine 100 mumol/L, and ribose 2 mmol/L demonstrated significant improvement (p less than 0.05) during postischemic reperfusion. A significant correlation (p less than 0.05) existed between myocardial adenosine triphosphate content and the recovery of left ventricular function. These experiments demonstrate that an asanguineous cardioplegic solution containing adenosine, hypoxanthine, and ribose maintains myocardial adenosine triphosphate content during ischemia and reperfusion and enhances functional recovery during the postischemic period.

This article has been cited by other articles:

				J. P. Headrick, R. Lasley, E. Kilpatrick, P. Narayan, and R. Mentzer Jr. Apparent Activation of Cardiovascular A1 Adenosine Receptors by A3 Agonists Am J Physiol Heart Circ Physiol, February 1, 2002; 282 (2): H793 - H796. [Full Text] [PDF]

				B. G. Fogelson, S. I. Nawas, and W. R. Law MECHANISMS OF MYOCARDIAL PROTECTION BY ADENOSINE-SUPPLEMENTED CARDIOPLEGIC SOLUTION: MYOFILAMENT AND METABOLIC RESPONSES J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 601 - 609. [Abstract] [Full Text] [PDF]

				D. F. Pauly and C. J. Pepine D-Ribose as a Supplement for Cardiac Energy Metabolism Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 249 - 258. [Abstract] [PDF]

				G. Dunphy, H. W. Richter, M. Azodi, J. Weigand, F. Sadri, F. Sellke, and D. Ely The effects of mannitol, albumin, and cardioplegia enhancers on 24-h rat heart preservation Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1591 - H1598. [Abstract] [Full Text] [PDF]

				J. A. Auchampach, A. Rizvi, Y. Qiu, X.-L. Tang, C. Maldonado, S. Teschner, and R. Bolli Selective Activation of A3 Adenosine Receptors With N6-(3-Iodobenzyl)Adenosine-5'-N-Methyluronamide Protects Against Myocardial Stunning and Infarction Without Hemodynamic Changes in Conscious Rabbits Circ. Res., June 19, 1997; 80(6): 800 - 809. [Abstract] [Full Text]

				M. H. Cox, S.-J. O, L. Hebbar, R. Mukherjee, F. A. Crawford Jr, and F. G. Spinale Protective Effects of Adenosine on Myocyte Contractility During Cardioplegic Arrest Ann. Thorac. Surg., April 1, 1997; 63(4): 981 - 987. [Abstract] [Full Text]

				O. Katayama, S. J. M. Ledingham, M. Amrani, R. T. Smolenski, D. R. Lachno, J. Jayakumar, and M. H. Yacoub Functional and Metabolic Effects of Adenosine in Cardioplegia: Role of Temperature and Concentration Ann. Thorac. Surg., February 1, 1997; 63(2): 449 - 454. [Abstract] [Full Text]

				R. D. Lasley and R. M. Mentzer Jr Protective Effects of Adenosine in the Reversibly Injured Heart Ann. Thorac. Surg., September 1, 1995; 60(3): 843 - 846. [Abstract] [Full Text]

				R. D. Lasley and R. M. Mentzer Jr. The role of adenosine in extended myocardial preservation with the University of Wisconsin solution J. Thorac. Cardiovasc. Surg., May 1, 1994; 107(5): 1356 - 1363. [Abstract] [Full Text]

				J. A. Herold, I. L. Kron, S. E. Langenburg, L. H. Blackbourne, and C. G. Tribble Complete prevention of postischemic spinal cord injury by means of regional infusion with hypothermic saline and adenosine J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 536 - 542. [Abstract] [Full Text]